Recent Updates
Recently added Catalysts
FULC Positive Sentiment

Fulcrum Therapeutics to Participate at the Cantor Fitzgerald Global Healthcare Conference

Friday, September 22, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, will participate in the Cantor Fitzgerald Global Healthcare Conference in New York on September 28, 2023. During the event, management will engage in a fireside chat addressing the company's efforts in treating genetically defined rare diseases. The presentation will be accessible through a webcast, with an archived replay available for 90 days on the company’s website.
Price reaction · baseline $4.09 (2023-09-21 close) · hit after-hours · clean, no other FULC news in the window
day 0 close
+2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Fulcrum Therapeutics is participating in a significant healthcare conference.
  • The event provides exposure and potential networking opportunities.
  • The company is focused on improving lives through innovative treatments.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
15.6%
average across 6 past catalysts
Cash runway
~59 mo
Minimal dilution risk
Lead asset
Pociredir
Phase 2 · Sickle Cell Disease

Full Press Release Details

CAMBRIDGE, Mass., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference, being held in New York, NY on Thursday, September 28, 2023 at 8:35 a.m. ET.
The webcast of the presentation will be accessible here and through the Investor Relations section of the Fulcrum website at https://ir.fulcrumtx.com/events-and-presentations. An archived replay will be available on the Company’s website for 90 days.
About Fulcrum Therapeutics

Frequently Asked Questions

When is Fulcrum Therapeutics' fireside chat?

The fireside chat is on September 28, 2023, at 8:35 a.m. ET.

Where can I watch the Fulcrum Therapeutics presentation?

The webcast will be available on the Investor Relations section of Fulcrum's website.

How long will the webcast replay be available?

The archived replay will be accessible for 90 days.

What is Fulcrum Therapeutics focused on?

Fulcrum Therapeutics aims to improve the lives of patients with rare genetic diseases.

ShareAdd on Google
Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics Cantor Fitzgerald healthcare conference genetically defined diseases biopharmaceutical
Last updated: Sep 22, 2023

Biotech snapshot

Cash runway
$319M liquidity · $5M/mo burn
~59 mo
Minimal dilution risk
Lead asset
PociredirPhase 2
Sickle Cell Disease →

Catalyst track record

+32%
best trade around FULC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for FULC.

See every catalyst's timing & PoA →